Most life sciences companies are aware that state laws impose expense limits and disclosure requirements concerning the marketing and promotion of prescription products. The trouble, however, lies in dealing with the intricacies and ongoing compliance difficulties created by differences among each state’s requirements.
Please click here to read the full article.